Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Two horses test positive for 
controlled substances
horse racing
A total of 137 horses were tested in the first week of the Equestrian Games.
Result could mean disqualification for fourth-placed French eventing team

The International Federation for Equestrian Sports FEI has announced that two horses competing in the World Equestrian Games have tested positive for Controlled Medication substances.

Controlled Medications are substances that are regularly used to treat horses but which are not allowed in competition in order to maintain a level playing field.
 
Samples taken on August 28 from the horse Tra Flama, ridden in Endurance by Giliese de Villiers from the Republic of South Africa, have returned positive for Phenylbutazone and its metabolite Oxyphenbutazone. Phenylbutazone is a non-steroidal anti-inflammatory used for the treatment of pain. Tra Flama was vetted out at the second Vet Gate on the Endurance course.
 
Samples taken on August 29 from the horse Qalao des Mers, ridden in Eventing by Maxime Livio of France, have returned positive for the Controlled Medication substance Acepromazine. Acepromazine is a sedative. Qalao des Mers finished fifth individually and was a member of the fourth-placed French team.

FEI Secretary General Ingmar De Vos said; "It is the first duty of a regulator to ensure clean sport and a level playing field and we do this by conducting an ongoing and very comprehensive testing programme. We had clean World Equestrian Games in 2010 in Kentucky and at the Olympic and Paralympic Games in 2012. Our system works and sends out a strong message to our athletes and their entourage that clean sport is our absolute top priority.
 
"We carried out an intensive awareness campaign prior to the Games and also offered pre-arrival testing to all participants, so it is very disappointing that we have two positives for Controlled Medication substances at the Games, especially when it is well known and well accepted that both these substances are not permitted in competition. Although these are Controlled Medication not doping substances, we take this very seriously."
 
The FEI has confirmed that all equine samples taken in the first week of the Games in the disciplines of Dressage, Para-Dressage and Reining are negative, and that there are no other positives in Endurance and Eventing. A total of 137 horses were tested in the first week of the Games – 49 in Endurance (28 per cent of 173 starters), 24 in Eventing (26
per cent of 91 starters), 22 in Dressage (22 per cent of 100 starters), 21 in Reining (26 per cent of 82 starters) and 21 in Para-Equestrian Dressage (21 per cent of 100 starters).

In addition to random testing, the FEI conducts compulsory testing of all individual medal winners at the World Equestrian Games, and at least one horse from each of the medal winning teams.

The Controlled Medication positives will not result in an automatic provisional suspension, but will go before the FEI Tribunal after the Games at a date to be agreed between all parties. As at the Olympic Games, a positive result for a team member can result in the disqualification of the whole team. In the Qalao des Mers case, this could mean disqualification of the French Eventing team and loss of Olympic qualification for Rio 2016. It is the role of the FEI Tribunal to rule on what sanctions apply.
 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.